We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
JRC scientists have been collaborating with EFSA experts on the development of an Adverse Outcome Pathway to establish the biological plausibility of an association between exposure to pesticides and Parkinson's disease.
JRC scientists have co-edited and contributed to a special issue of Toxicology and Applied Pharmacology proposing how alternative methods to animal testing can be used to assess chemicals for their potential to disrupt brain development in children
In an international collaboration of regulators and industry, JRC scientists contributed to the compilation of overarching principles for the safety assessment of cosmetics without animal testing.
JRC scientists have published a series of papers assessing the availability and applicability of computational models in the safety assessment of nanomaterials, with a view to promoting their further development and use in regulatory decision making.
JRC scientists have contributed to the editing and writing of a book on the history of alternative methods in toxicology and chemical safety assessment.
The book presents historical perspectives on the development, validation, acceptance and use of alternatives to animal testing over the past half-century, with an emphasis on humanity and good science, in line with the Three Rs (Replacement, Reduction, Refinement of animal procedures).
The annual conference of the European Partnership for Alternative Approaches to Animal Testing (EPAA) took place on 20 November 2018 in Brussels. The event showcased recent EPAA achievements and included an expert panel session, with the participation of the JRC, that discussed how new types of safety data derived from alternative methods can be exploited in regulatory decision making.
JRC scientists are part of an international initiative developing principles and protocols for the consistent use of computational models in chemical safety assessment to promote greater acceptance in regulatory applications.
The In Silico Toxicology (IST) Protocol initiative is focusing on how results from computational methods should be generated, interpreted, assessed and documented with a view to increasing confidence in their use.
JRC contributed to research carried out by Italian research organisations in Pavia and Milan. This work demonstrated that new 3D in vitro cell based models can be applied to assess the neurotoxicity of magnetite nanoparticles. 3D cultures may represent good "near-to-in-vivo" models leading to better interpretation of toxicological effects to humans.
Highlights of the JRC work presented include using Adverse Outcome Pathways to guide in vitro method development, the recently published OECD guidance on good in vitro method practices, results of an international survey on validating complex in vitro models, and an update of the JRC validation study of in vitro methods for identifying thyroid disrupters.
JRC scientists have contributed to the revision of OECD Guidance Document 23 "Aqueous-Phase Aquatic Toxicity Testing of Difficult Test Chemicals" that addresses good practices to be applied in aquatic toxicity testing.